Pielotax
Longevity & Cellular HealthAlso known as: Kidney Bioregulator, Khavinson Kidney Peptide, Renal Bioregulator
Mechanism
Pielotax is a peptide bioregulator designed to support kidney health and function. The kidneys filter 200 liters of blood daily, regulate electrolytes, produce erythropoietin (for red blood cell production), and activate vitamin D. Kidney function naturally declines with age — losing about 1% of filtration capacity per year after age 40. Pielotax targets kidney tissue to help maintain filtration capacity, tubular function, and the kidney's hormonal roles by restoring age-disrupted gene expression patterns.
Technical detail
Pielotax is a short-chain peptide bioregulator from the Khavinson series targeting renal parenchymal cells — including glomerular podocytes, proximal and distal tubular epithelial cells, and mesangial cells. Proposed mechanism: nuclear DNA interaction in nephron cells to modulate expression of genes governing glomerular filtration barrier integrity (nephrin, podocin), tubular transport proteins (aquaporins, sodium-glucose cotransporters), and renal hormonal function (erythropoietin gene expression, 1-alpha-hydroxylase for vitamin D activation). May support mesangial cell homeostasis and reduce age-related glomerulosclerosis by modulating TGF-β and connective tissue growth factor (CTGF) expression. Consistent with Khavinson peptide bioregulation paradigm. Limited published data from Khavinson group.
Effects
RENAL: Primary target system. Kidney function (GFR) declines ~1 mL/min/1.73m2 per year after age 40 — from ~120 mL/min at age 30 to ~60 mL/min by age 90. This decline involves loss of nephrons (functional units), glomerulosclerosis, tubular atrophy, and interstitial fibrosis. Pielotax targets renal parenchymal cells to support gene expression in: (1) Glomerular podocytes — maintain filtration barrier integrity via nephrin, podocin, and WT-1 expression; podocyte loss is the rate-limiting step in progressive kidney disease; (2) Proximal tubular cells — responsible for reabsorption of 65% of filtered sodium, glucose, amino acids, and phosphate; express megalin/cubilin for protein reabsorption; (3) Distal tubule and collecting duct — fine-tuning of electrolyte balance, acid-base homeostasis, and water reabsorption (aquaporin-2 expression regulated by vasopressin). ENDOCRINE: Kidneys produce erythropoietin (EPO) for red blood cell production — EPO declines with kidney aging, contributing to anemia of chronic kidney disease. Also express 1-alpha hydroxylase (CYP27B1) that converts 25(OH)D to active 1,25(OH)2D — kidney decline reduces active vitamin D. The renin-angiotensin system originates in juxtaglomerular cells. CARDIOVASCULAR: Kidney function directly affects blood pressure (renin-angiotensin, sodium handling) and fluid balance. Kidney disease is the strongest risk factor for cardiovascular death after age 65. METABOLIC: Kidneys clear metabolic waste (urea, creatinine, uric acid), regulate acid-base balance, and gluconeogenesis (contributes ~20% of fasting glucose production). Tier 3: Users report improved kidney function markers (creatinine, cystatin C, eGFR), reduced proteinuria, and better blood pressure control after 2-3 courses.
Practitioner Guide
DOSING TIPS: Standard protocol: 1-2 capsules daily for 10-30 days, repeated every 3-6 months. For kidney support: 2 capsules daily for 30 days. Take with meals. SUPPLEMENT SYNERGIES: Astragalus (1000-2000mg/day standardized extract) — traditional nephroprotective herb with modern evidence for CKD support. CoQ10 (200-400mg/day ubiquinol) — mitochondrial support for energy-demanding tubular cells. Omega-3 fatty acids (2-4g/day EPA+DHA) — anti-inflammatory, reduce proteinuria. Sodium bicarbonate supplementation if metabolic acidosis is present (under medical supervision). Adequate hydration (critical). Avoid excessive protein intake if eGFR <60. CYCLING: Standard Khavinson protocol. CONTRAINDICATION NUANCES: End-stage renal disease on dialysis — bioregulators cannot restore destroyed nephrons. Renal transplant patients on immunosuppressants — unknown interactions. Active nephritis — treat underlying condition first. Patients with renal artery stenosis — address vascular issue. STORAGE: Room temperature. PATIENT EDUCATION: Your kidneys filter your entire blood volume 40 times per day — they are the hardest-working organs per gram of tissue. Kidney function declines silently with age and cannot be fully recovered once lost. This bioregulator aims to help your remaining kidney cells work at their best. Get baseline labs: serum creatinine, cystatin C, eGFR, urine albumin-to-creatinine ratio, and basic metabolic panel.
Research Summary
TIER 1 (Gold Standard): No Western clinical trials. TIER 2 (Strong): Khavinson bioregulation theory. Kidney aging physiology well-established — nephron loss, GFR decline, tubulointerstitial fibrosis (ASN educational materials). TIER 3 (Moderate): Khavinson group renal bioregulator publications. Practitioner reports. KEY FINDINGS: (1) Kidney is a high-value bioregulator target due to irreversible nephron loss. (2) No independent validation. GAPS: Standard Khavinson gaps.